| PMVEX | VMVAX | PMVEX / VMVAX | |
| Total Expense Ratio | 1.23 | 0.07 | 1,757% |
| Annual Report Gross Expense Ratio | 17.84 | 0.07 | 25,486% |
| Fund Existence | 9 years | 15 years | - |
| Gain YTD | 22.858 | 15.500 | 147% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 194M | 37.2B | 1% |
| Annual Yield % from dividends | 0.83 | 1.81 | 46% |
| Returns for 1 year | 34.13 | 22.51 | 152% |
| Returns for 3 years | 58.07 | 44.10 | 132% |
| Returns for 5 years | 63.24 | 46.55 | 136% |
| Returns for 10 years | N/A | 127.98 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VZGRX | 60.67 | 0.98 | +1.64% |
| Virtus Zevenbergen Innovative Gr Stk R6 | |||
| HDGYX | 40.50 | 0.30 | +0.75% |
| Hartford Dividend and Growth Y | |||
| GPRIX | 14.76 | 0.08 | +0.54% |
| Grandeur Peak Global Reach Instl | |||
| BGEKX | 14.48 | -0.04 | -0.28% |
| Baillie Gifford International Growth K | |||
| NBHCX | 16.44 | -0.07 | -0.42% |
| Neuberger Equity Income C | |||